Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James N Ingle

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Breast Cancer Research : BCR|December 22, 2010
Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associationsJames N Ingle
Breast Cancer Research : BCR|January 9, 2009
Introduction to sessions on 'Endocrine therapy: where have we come from, where are we at and where are we going to'?James N Ingle
Journal of Human Genetics|May 3, 2013
Pharmacogenomics of endocrine therapy in breast cancerJames N Ingle
Breast (Edinburgh, Scotland)|October 1, 2013
Postmenopausal women with hormone receptor-positive breast cancer: balancing benefit and toxicity from aromatase inhibitorsJames N Ingle
Breast Cancer Research : BCR|July 9, 2002
Estrogen as therapy for breast cancerJames N Ingle
The Breast Journal|October 23, 2002
Sequencing of hormonal therapy in breast cancerJames N Ingle
Steroids|March 9, 2011
Overview of adjuvant trials of aromatase inhibitors in early breast cancerJames N Ingle
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Sequencing of endocrine therapy in postmenopausal women with advanced breast cancerJames N Ingle
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settingsJames N Ingle
Cancer|December 12, 2007
Pharmacogenomics of tamoxifen and aromatase inhibitorsJames N Ingle
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Breast Cancer Research : BCR|December 22, 2010
Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associationsJames N Ingle
Breast Cancer Research : BCR|January 9, 2009
Introduction to sessions on 'Endocrine therapy: where have we come from, where are we at and where are we going to'?James N Ingle
Journal of Human Genetics|May 3, 2013
Pharmacogenomics of endocrine therapy in breast cancerJames N Ingle
Breast (Edinburgh, Scotland)|October 1, 2013
Postmenopausal women with hormone receptor-positive breast cancer: balancing benefit and toxicity from aromatase inhibitorsJames N Ingle
Breast Cancer Research : BCR|July 9, 2002
Estrogen as therapy for breast cancerJames N Ingle
The Breast Journal|October 23, 2002
Sequencing of hormonal therapy in breast cancerJames N Ingle
Steroids|March 9, 2011
Overview of adjuvant trials of aromatase inhibitors in early breast cancerJames N Ingle
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Sequencing of endocrine therapy in postmenopausal women with advanced breast cancerJames N Ingle
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settingsJames N Ingle
Cancer|December 12, 2007
Pharmacogenomics of tamoxifen and aromatase inhibitorsJames N Ingle
Pageof 27